Choosing an antihypertensive combination with a more efficient central blood pressure reduction

[1]  G. Bakris,et al.  The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol. , 2010, The American journal of medicine.

[2]  Teemu J Niiranen,et al.  Home-Measured Blood Pressure Is a Stronger Predictor of Cardiovascular Risk Than Office Blood Pressure: The Finn-Home Study , 2009, Hypertension.

[3]  Richard B Devereux,et al.  High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. , 2009, Journal of the American College of Cardiology.

[4]  J. Staessen,et al.  Night–day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension , 2009, Journal of Human Hypertension.

[5]  Giuseppe Mancia,et al.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document , 2009, Blood pressure.

[6]  Riccardo Pini,et al.  Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. , 2008, Journal of the American College of Cardiology.

[7]  Y. Lacourciére,et al.  Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements , 2003, Journal of hypertension.

[8]  T. Hedner,et al.  Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. , 1992, Blood pressure.